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Response to Letter by Proctor
Response:
Dr Proctor1 raises several important issues which concur with
Amoro and colleagues’ conclusion2 that the potential benefits of
elevated serum uric acid are independent of the likely relation-
ship between chronically elevated serum uric acid and cardio-
vascular disease. Thanks to Amoro et al, there is now data from
both the basic science and clinical research arenas to suggest that
infusion of uric acid after stroke could reduce free radical–
mediated injury, a potential treatment for an area sorely in need
of an advance. However, as discussed, data exist to support uric
acid reduction as a preventative strategy in those at risk of
atherosclerotic disease.
It seems unlikely, however plausible, that explanations for a
circumstantial beneficial or detrimental effect of uric acid may be
that these differences will not lead to confusion in wider
nonspecialist circles. Such confusion could ultimately hinder
adoption of these strategies in either research or clinical circles—
“you want me to administer uric acid, but I thought uric acid was
bad for you?” As such, we welcome the attention given to this
area in recent issues of Stroke.
Proctor also highlights evidence suggesting that uric acid itself
may mediate oxidative stress–related damage, rather than this
being a consequence of its mechanism of generation (xanthine
oxidase activity). Again, there is evidence for (some of which he
highlights) and against this hypothesis. A series of elegant
studies by Struthers et al3 suggest that the beneficial effects of
allopurinol on a variety of measures of endothelial function relate
to a reduction in xanthine oxidase activity, and not uric acid
reduction while other data suggest uric acid reduction is impor-
tant.4 Clearly, more studies are needed to disentangle causal
mechanisms so we can better direct evaluation of potential
therapies.
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